N-Ethylhexedrone was patented from the German pharmaceutical enterprise Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[one]The toxicity and very long-time period overall health consequences of recreational N-ethylhexedrone use tend not to seem to have